Related references
Note: Only part of the references are listed.Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis
Francisco Espejo-Porras et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities
Constanza J. Cortes et al.
NEUROBIOLOGY OF DISEASE (2019)
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pal Pacher et al.
NATURE REVIEWS CARDIOLOGY (2018)
Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
Xiao Wei et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Molecular mechanisms of cardiac pathology in diabetes - Experimental insights
U. Varma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy
Yang Xiao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Autophagy in health and disease: A comprehensive review
Sarbari Saha et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Resveratrol Modulates Apoptosis and Autophagy Induced by High Glucose and Palmitate in Cardiac Cells
Kui Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation
Patrizia Ratano et al.
NEUROPHARMACOLOGY (2018)
Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress
Zhaohui Pei et al.
TOXICOLOGY LETTERS (2018)
Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
Xavier Palomer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity
Guan Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ss/Fyn pathway
Ying Xin et al.
REDOX BIOLOGY (2018)
Autophagy was involved in the protective effect of metformin on hyperglycemia-induced cardiomyocyte apoptosis and Connexin43 downregulation in H9c2 cells
Guang-Yu Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway
Mingqiu Cen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling
Mingming Zhang et al.
JOURNAL OF PINEAL RESEARCH (2017)
AMPK activation restores ischemic post-conditioning cardioprotection in STZ-induced type 1 diabetic rats: Role of autophagy
Bin Zhou et al.
MOLECULAR MEDICINE REPORTS (2017)
Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation
Dong Han et al.
ONCOTARGET (2017)
Exogenous H2S Protects Against Diabetic Cardiomyopathy by Activating Autophagy via the AMPK/mTOR Pathway
Fan Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists
Leonid N. Maslov et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)
The roles of macrophage autophagy in atherosclerosis
Bo-zong Shao et al.
ACTA PHARMACOLOGICA SINICA (2016)
Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice
Xiang Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells
Qing-Qing Wu et al.
CLINICAL SCIENCE (2016)
Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice
Xiaohong Wang et al.
DIABETES (2016)
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages
Lisheng Jiang et al.
LIFE SCIENCES (2016)
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway
Timothe Denaes et al.
SCIENTIFIC REPORTS (2016)
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
Ping Ke et al.
PLOS ONE (2016)
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
Demetrios Moris et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome
Bo-Zong Shao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
Federica Barutta et al.
KIDNEY INTERNATIONAL (2014)
Autophagy-a key player in cellular and body metabolism
Kook Hwan Kim et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart
Wang YaBin et al.
SCIENCE CHINA-LIFE SCIENCES (2014)
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
Sabine Steffens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
Sarah Rosner Preis et al.
CIRCULATION (2009)
Diabetic cardiomyopathy: A metabolic perspective
A Avogaro et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Share Paper
